The Functional Neuroanatomy of the Human Physiological Stress Response
Hypo fMRI
1 other identifier
interventional
74
1 country
2
Brief Summary
The purpose of this study is to examine the effect of a moderately low blood sugar stress on the nervous system. The investigators hope that information obtained from completing this study will help to reveal information about how a non-psychological stress impacts the parts of the brain that react to stress and the autonomic nervous system. The autonomic nervous system is the part of the nervous system that provides the body with involuntary or automatic control of heart rate, blood pressure, and breathing.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2019
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 4, 2019
CompletedFirst Posted
Study publicly available on registry
March 8, 2019
CompletedStudy Start
First participant enrolled
October 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2025
CompletedJanuary 5, 2026
December 1, 2025
6.3 years
March 4, 2019
December 30, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Effect of physiological stress (hypoglycemia) on brain networks involved in autonomic function
Functional MRI will be performed following physiological stress (hypoglycemia) or placebo (normoglycemia) and a functional connectivity analysis will be performed on the fMRI data. The outcome will be alterations in neural network connectivity, as measured by changes in Pearson-correlation coefficients among the following brain structures: right anterior insula and anterior cingulate cortex; right anterior insula and hypothalamus; hypothalamus and anterior cingulate cortex; hypothalamus and amygdala; locus coeruleus and hypothalamus.
Baseline, 8 hours after physiological stress, and 4 days after physiological stress
The relationship over time between stress-induced changes in brain networks and stress-induced changes in baroreflex sensitivity
The stress-induced change in baroreflex sensitivity (msec/mmHg) will be determined. Pearson correlation coefficients (r) between the changes in baroreflex sensitivity and the changes in brain connectivity (right anterior insula and anterior cingulate cortex; hypothalamus and amygdala \[determined for the first outcome above\]) will be calculated and tested for significance.
Baseline, 8 hours after physiological stress, and 4 days after physiological stress
Study Arms (2)
Hypoglycemia
ACTIVE COMPARATORParticipants undergo Autonomic Nervous System (ANS) Testing (measurement of Baroreflex Sensitivity using the Modified Oxford test) followed by a functional MRI (fMRI) scan. The next day, participants undergo one 120-minute hypoglycemic hyperinsulinemic clamp procedure (50mg/dL) in the morning followed by ANS Testing and an fMRI scan. Four days later, participants undergo repeat ANS Testing and an fMRI scan.
Normoglycemia
PLACEBO COMPARATORParticipants undergo Autonomic Nervous System (ANS) Testing (measurement of Baroreflex Sensitivity using the Modified Oxford test) followed by a functional MRI (fMRI) scan. The next day, participants undergo one 120-minute normoglycemic hyperinsulinemic clamp procedure (90mg/dL) in the morning followed by ANS Testing and an fMRI scan. Four days later, participants undergo repeat ANS Testing and an fMRI scan.
Interventions
Participants undergo a 120-minute hypoglycemic hyperinsulinemic clamp procedure.
Participants undergo a 120-minute normoglycemic hyperinsulinemic clamp procedure.
Eligibility Criteria
You may qualify if:
- Healthy volunteers
- Males and Females age 18 to 45 years
- BMI 18-35 kg/m2
You may not qualify if:
- Pregnancy
- Lactation
- Menopause
- Any medical condition
- Current or prior alcohol or drug abuse
- Active tobacco use
- Abnormal ECG
- In all subjects, any individuals on oral, injected, inhaled or topical corticosteroids within the last year or oral contraceptives within the past 3 months will be excluded.
- Use of medications other than thyroid hormone or hormonal birth control
- Serum potassium \>5.0 mmol/L
- Estimated GFR \<60 mL/min/1.73 m2
- Hemoglobin A1c ≥6.5%
- Patient Health Questionnaire (PHQ9) for depression score ≥15
- GAD-7 Questionnaire for anxiety score ≥10
- PTSD Checklist for DSM-5 (PCL-5) score ≥31
- +3 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Brigham and Women's Hospitallead
- Beth Israel Deaconess Medical Centercollaborator
- Boston Children's Hospitalcollaborator
- Mclean Hospitalcollaborator
Study Sites (2)
Beth Israel Deaconess Medical Center
Boston, Massachusetts, 02115, United States
Brigham and Women's Hospital
Boston, Massachusetts, 02115, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Roy Freeman, MD
Beth Israel Deaconess Medical Center
- PRINCIPAL INVESTIGATOR
Gail K Adler, MD, PhD
Brigham and Women's Hospital
- PRINCIPAL INVESTIGATOR
David Borsook, MD, PhD
Boston Children's Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
March 4, 2019
First Posted
March 8, 2019
Study Start
October 1, 2019
Primary Completion
December 30, 2025
Study Completion
December 30, 2025
Last Updated
January 5, 2026
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will share
- Time Frame
- Data will be shared after completion of study and initial publications which we anticipate to be within 18 months of the final participant completing the study protocol.
- Access Criteria
- Access to data must be approved by the IRB at our institution.
The data collected will comply with the NIH requirements for timely release and data sharing. Data will be shared in the form of publications and presentations in scientific forums. As the NIH has noted, the investigators reserve the right to keep the data restricted in order to perform the initial analyses for this grant proposal and will continue to use the data for further, but not prolonged, exclusive use. Of note, the sharing of this data will be limited by at least the following issues, some unique to this proposal and some not unique. Some of the data obtained in this study is defined to be sensitive in nature, which may restrict its ability to be shared. Data may only be shared with the approval of our IRB and is limited by HIPPA and any other regulations that may be promulgated during the course of this proposal.